Impact of mercaptopurine schedule on hypoglycemia in leukemic children: randomized trial and risk factor analysis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hypoglycemia is common in children receiving mercaptopurine (6-MP) chemotherapy. Shortening overnight fasting is key to prevention, not changing the 6-MP schedule.
Area Of Science
- Pediatric Oncology
- Pharmacology
- Clinical Chemistry
Background
- Hypoglycemia is a risk in children with acute lymphoblastic leukemia (ALL) treated with mercaptopurine (6-MP).
- Hypoglycemia can negatively impact neurodevelopment in children.
- Understanding 6-MP's role in hypoglycemia beyond maintenance therapy is crucial.
Purpose Of The Study
- To investigate hypoglycemia occurrence in children with ALL receiving 6-MP chemotherapy.
- To identify risk factors for hypoglycemia during 6-MP treatment.
- To compare hypoglycemia incidence with different 6-MP administration timings.
Main Methods
- Patients with ALL received the CAM-1 regimen including 6-MP.
- 6-MP administration was randomized to nighttime (Group A) or afternoon (Group B).
- Children with acute myeloid leukemia (Group C) received chemotherapy without 6-MP for comparison.
Main Results
- No hypoglycemia was observed in Group C (no 6-MP).
- 33% of patients on CAM-1 developed hypoglycemia, with 48% symptomatic.
- No significant difference in hypoglycemia rates between Group A and Group B was found.
- Younger age, elevated bilirubin, and longer overnight fasting were identified as risk factors for hypoglycemia.
Conclusions
- Hypoglycemia is prevalent even with short-term 6-MP exposure.
- 6-MP is directly associated with hypoglycemia in pediatric patients.
- Reducing overnight fasting duration is critical for preventing hypoglycemia and protecting neurodevelopment in children receiving 6-MP.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...